Abstract CP-158 Table 1

	Baseline (n = 19)	15 days (n = 17)	3 months (n = 17)	1 year (n = 16)	1.5 years (n = 16)	2 years (n = 15)

T25FW (seconds)	21 ± 16.4	13.2 ± 10.2	14.9 ± 16.4	14.4 ± 14.5	9.8 ± 6.5	10.6 ± 6.6
Average increase in T25FW speed from baseline (ΔV) (%)		62.2 ± 57.9	59.8 ± 44.6	50.4 ± 23.3	61.7 ± 23.7	49.7 ± 25.8
% patients with ΔV ≥20%		94.1	88.2	87.5	100	92.9
MSWS-12 (points)	47.9 ± 9.2	37.4 ± 8.8	36.7 ± 7.6	40 ± 9.8	43.3 ± 10.2	38.6 ± 10.41
MSWS-12 reduction (points)		11.9 ± 8.2	12.7 ± 7.8	9.2 ± 7.3	6.4 ± 5.8	10.7 ± 9.13
% patients with MSWS-12 reduction ≥ 6 points		70.6	82.4	75	50	57.1
% responding patients		64.7	70.6	62.5	50	58.3
EDSS	5.9 ± 0.6			5.9 ± 0.79	5.67 ± 0.8	5.9 ± 0.78